Company / SG&A Expense
Penumbra, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$663.4M
FY2025
5-year range
$272.7M / $663.4M
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#58 of 158
Health Care
What the data says
At $663M, Penumbra, Inc.'s sg&a expense ranks #101 of 158 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $273M in FY2021 to $663M in FY2025.
Based on SEC 10-K filings.
$663M in FY2025 with a 5-year CAGR of +18.2%.
Increased from $506M to $663M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +32.2%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
#101 of 158 in Health CareTop 63% of 158This company $663.4M Sector average $175.9B
▼
-99.6% below sector average
Key checks
Key Insights
- Penumbra, Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +18.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 15.6% year-over-year.
- Ranks #58 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $663.4M | +15.6% |
| FY2024 | $574.0M | +13.3% |
| FY2023 | $506.5M | +76.4% |
| FY2022 | $287.1M | +5.3% |
| FY2021 | $272.7M | -5.0% |
| FY2020 | $287.1M | +55.7% |
| FY2019 | $184.3M | +24.3% |
| FY2018 | $148.3M | +45.6% |
| FY2017 | $101.9M | -31.3% |
| FY2016 | $148.3M | +45.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026